Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus

N. Ogawa, Masato Asanuma, K. Mizukawa, H. Hirata, H. Chou, A. Mori

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R mRNA levels were carried out in the gerbil hippocampus 14 days after 5 min of transient ischemia. Both were reduced in the ischemic tissue to about 50% of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably decreased synthesis. Three administrations of bifemelane hydrochloride (15 mg/kg, i.p., just after ischemia and 6 and 12 h later) completely prevented neuronal death in the hippocampus and ischemia-induced losses of hippocampal M1-R and its mRNA. Since vascular dementia may depend upon the ischemia-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane hydrochloride.

Original languageEnglish
Pages (from-to)171-175
Number of pages5
JournalBrain Research
Volume591
Issue number1
DOIs
Publication statusPublished - Sep 18 1992

Fingerprint

Muscarinic M1 Receptors
Gerbillinae
Hippocampus
Ischemia
Messenger RNA
Vascular Dementia
Cholinergic Receptors
Cholinergic Agents
Communication
Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate
bifemelane

Keywords

  • Bifemelane hydrochloride
  • Ischemia-induced depletion
  • Muscarinic M receptor
  • Muscarinic M-receptor messenger RNA
  • Post-ischemic administration
  • Prevention

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus. / Ogawa, N.; Asanuma, Masato; Mizukawa, K.; Hirata, H.; Chou, H.; Mori, A.

In: Brain Research, Vol. 591, No. 1, 18.09.1992, p. 171-175.

Research output: Contribution to journalArticle

@article{0487bf14a24d4cbe8ff2ed9dcfccaa54,
title = "Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus",
abstract = "Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R mRNA levels were carried out in the gerbil hippocampus 14 days after 5 min of transient ischemia. Both were reduced in the ischemic tissue to about 50{\%} of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably decreased synthesis. Three administrations of bifemelane hydrochloride (15 mg/kg, i.p., just after ischemia and 6 and 12 h later) completely prevented neuronal death in the hippocampus and ischemia-induced losses of hippocampal M1-R and its mRNA. Since vascular dementia may depend upon the ischemia-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane hydrochloride.",
keywords = "Bifemelane hydrochloride, Ischemia-induced depletion, Muscarinic M receptor, Muscarinic M-receptor messenger RNA, Post-ischemic administration, Prevention",
author = "N. Ogawa and Masato Asanuma and K. Mizukawa and H. Hirata and H. Chou and A. Mori",
year = "1992",
month = "9",
day = "18",
doi = "10.1016/0006-8993(92)90993-J",
language = "English",
volume = "591",
pages = "171--175",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus

AU - Ogawa, N.

AU - Asanuma, Masato

AU - Mizukawa, K.

AU - Hirata, H.

AU - Chou, H.

AU - Mori, A.

PY - 1992/9/18

Y1 - 1992/9/18

N2 - Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R mRNA levels were carried out in the gerbil hippocampus 14 days after 5 min of transient ischemia. Both were reduced in the ischemic tissue to about 50% of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably decreased synthesis. Three administrations of bifemelane hydrochloride (15 mg/kg, i.p., just after ischemia and 6 and 12 h later) completely prevented neuronal death in the hippocampus and ischemia-induced losses of hippocampal M1-R and its mRNA. Since vascular dementia may depend upon the ischemia-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane hydrochloride.

AB - Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R mRNA levels were carried out in the gerbil hippocampus 14 days after 5 min of transient ischemia. Both were reduced in the ischemic tissue to about 50% of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably decreased synthesis. Three administrations of bifemelane hydrochloride (15 mg/kg, i.p., just after ischemia and 6 and 12 h later) completely prevented neuronal death in the hippocampus and ischemia-induced losses of hippocampal M1-R and its mRNA. Since vascular dementia may depend upon the ischemia-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane hydrochloride.

KW - Bifemelane hydrochloride

KW - Ischemia-induced depletion

KW - Muscarinic M receptor

KW - Muscarinic M-receptor messenger RNA

KW - Post-ischemic administration

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=0026722870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026722870&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90993-J

DO - 10.1016/0006-8993(92)90993-J

M3 - Article

C2 - 1446228

AN - SCOPUS:0026722870

VL - 591

SP - 171

EP - 175

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -